US 6964980
Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
expired A61KA61K31/405A61K31/427
Quick answer
US patent 6964980 (Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids) held by The Institute for Pharmaceutical Discovery, LLC expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Institute for Pharmaceutical Discovery, LLC
- Grant date
- Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/405, A61K31/427, A61K31/428, A61K31/4439